Pharma Manufacturing · Jun 2026
External coverage of the LV launch, emphasizing the platform expansion into LV manufacturing and the CHO/biologics direction.
Enabling next generation medicines. A comprehensive platform and…
Company research
Public company, workplace, funding, and market signals
Overview
64x Bio is a Brisbane, California-based biotechnology company spun out of Harvard/Wyss that builds the VectorSelect platform and Apex Suite product lines to engineer higher-yield production cell lines and manufacturing systems for advanced therapies, especially AAV and lentiviral vectors, with biologics expansion underway.
Primary product
VectorSelect platform (including AAV Apex Suite and LV Apex Suite)
Founded
2018
Headquarters
1000 Marina Blvd, Suite 100, Brisbane, CA 94005
Team size
10-20
Industry
Biotechnology Research
Sub-industry
Synthetic biology / gene therapy manufacturing
Offices
Brisbane, CA
Open Positions
0 jobs at 64x Bio
No open positions
Check back later for new openings